AngioDynamics, Inc. (ANGO) Stock Forecast
Data as of Jun 16, 2026Healthcare · Current price $12.14 (+1.50%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Jul 16, 2025 | John Young | Canaccord Genuity | $17.00 | +40.0% |
| Oct 4, 2024 | William Plovanic | Canaccord Genuity | $12.00 | -1.2% |
| Sep 20, 2024 | Yi Chen | H.C. Wainwright | $14.00 | +15.3% |
| Apr 5, 2024 | Steven Lichtman | Oppenheimer | $12.00 | -1.2% |
Top Analysts Covering ANGO
ANGO vs Sector & Market
| Metric | ANGO | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.00 | 2.24 | 2.41 |
| Analyst Count | 1 | 8 | 19 |
| Target Upside | +36.0% | +11475.0% | +17.1% |
| P/E Ratio | -14.55 | 4.04 | 31.98 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-08-28 | $78M | $79M | $80M | 2 |
| 2026-11-28 | $81M | $82M | $83M | 1 |
| 2027-02-28 | $82M | $83M | $83M | 1 |
| 2027-05-28 | $85M | $86M | $86M | 1 |
| 2027-05-31 | $324M | $330M | $335M | 3 |
| 2028-05-31 | $348M | $348M | $348M | 3 |
| 2029-05-31 | $365M | $368M | $370M | 1 |
| 2030-05-31 | $389M | $392M | $394M | 2 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-08-28 | $-0.11 | $-0.10 | $-0.07 | 2 |
| 2026-11-28 | $-0.05 | $-0.05 | $-0.05 | 1 |
| 2027-02-28 | $-0.02 | $-0.02 | $-0.02 | 1 |
| 2027-05-28 | $0.01 | $0.01 | $0.01 | 1 |
| 2027-05-31 | $-0.25 | $-0.16 | $-0.06 | 2 |
| 2028-05-31 | $-0.05 | $-0.03 | $-0.02 | 3 |
| 2029-05-31 | $0.19 | $0.19 | $0.19 | 1 |
| 2030-05-31 | $0.29 | $0.29 | $0.29 | 1 |
Frequently Asked Questions
What is the analyst consensus for ANGO?
The consensus among 1 analysts covering AngioDynamics, Inc. (ANGO) is Buy with an average price target of $16.50.
What is the highest price target for ANGO?
The highest price target for ANGO is $17.00, set by John Young at Canaccord Genuity on 2025-07-16.
What is the lowest price target for ANGO?
The lowest price target for ANGO is $12.00, set by Steven Lichtman at Oppenheimer on 2024-04-05.
How many analysts cover ANGO?
1 analysts have issued ratings for AngioDynamics, Inc. in the past 12 months.
Is ANGO a buy or sell right now?
Based on 1 analyst ratings, ANGO has a consensus rating of Buy (2.00/5) with a +36.0% upside to the consensus target of $16.50.
What are the earnings estimates for ANGO?
Analysts estimate ANGO will report EPS of $-0.10 for the period ending 2026-08-28, with revenue estimated at $79M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.